A Multicenter Study in Liver Transplant Patients Converted From Prograf® to Advagraf® During the First Post-transplantation Year

• Status: Completed
• Trial end date: 2017-05-03
• Target enrollment: 0
• Participant gender: All

Summary

A study in which two groups of patients will be analysed; patients converted from Prograf to Advagraf within the first 3 months after transplantation and patients converted from Prograf to Advagraf between 3 months and 1 year after transplantation.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Astellas Pharma S.A.S.
• Treatments: Tacrolimus

Criteria

Inclusion Criteria:

• Patient with a liver transplant performed in the previous year and for whom the conversion from Prograf® to Advagraf® was decided by the physician.

Exclusion Criteria:

• Patient participating in an interventional clinical trial at the time of enrolment into the study.